CareDx to Participate in Wells Fargo Healthcare Conference

Audio By Carbonatix

BRISBANE, Calif.--(BUSINESS WIRE)--Aug 21, 2025--

CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers — today announced the company will participate in a fireside chat at the Wells Fargo Healthcare Conference in Boston, Massachusetts , on September 5, 2025, at 8:00 AM ET.

A live and archived webcast of the presentation will be available on the “Events and Presentations” section of the CareDx investor relations website at investors.caredx.com.

About CareDx – The Transplant Company

CareDx, Inc., headquartered in Brisbane, California, is a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. For more information, visit www.caredx.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20250821836143/en/

CONTACT: Investor Relations

Caroline Corner

[email protected]

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA MASSACHUSETTS

INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES SURGERY RESEARCH SCIENCE PHARMACEUTICAL BIOTECHNOLOGY

SOURCE: CareDx, Inc.

Copyright Business Wire 2025.

PUB: 08/21/2025 04:01 PM/DISC: 08/21/2025 04:02 PM

http://www.businesswire.com/news/home/20250821836143/en